お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
デフォルト表紙
市場調査レポート
商品コード
925381

スコポラミンの世界市場:成長、動向、予測(2020年~2025年)

Scopolamine Market - Growth, Trends, and Forecast (2020 - 2025)

出版日: | 発行: Mordor Intelligence Pvt Ltd | ページ情報: 英文 120 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=109.93円
スコポラミンの世界市場:成長、動向、予測(2020年~2025年)
出版日: 2020年02月01日
発行: Mordor Intelligence Pvt Ltd
ページ情報: 英文 120 Pages
納期: 2-3営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界のスコポラミン市場では、2020年から2025年の期間にわたってCAGRが6%になると予想されます。市場の成長は、乗り物酔いの蔓延と意識の高まりによるものです。心理的ストレスは、乗り物酔いの主な要因の1つです。これらの心理的要因は、腸の感受性と中枢神経系の変化に影響を与えます。また、経皮パッチなどの新規ドラッグデリバリーシステムの導入とこれらの剤形の適応により、予測期間中の市場の成長を後押しすると予想されます。 さらに、世界中の旅行者数の増加、慢性疾患による手術件数の増加が市場の成長を促進と予想されます。ただし、スコポラミンの誤用、副作用、および厳しい規制政策は、予測期間中の市場の成長を妨げると予想されます。

当レポートは世界のスコポラミン市場について調査しており、市場機会や動向、成長および抑制要因、セグメント別や地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 イントロダクション

  • 調査成果
  • 調査の前提条件
  • 調査範囲

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場概要
  • 市場成長要因
    • 慢性疾患による外科的介入の増加
    • 医療費の増加とスコポラミンの適応
  • 市場抑制要因
    • スコポラミンの副作用と誤用
    • 厳しい規制政策
  • ポーターのファイブフォース分析
    • 新規参入の脅威
    • バイヤー/消費者の交渉力
    • サプライヤーの交渉力
    • 代替製品の脅威
    • 競争の激化

第5章 市場区分

  • 剤形別
    • 注射剤
    • タブレット
    • 経皮パッチ
    • その他
  • 流通チャネル別
    • 病院薬局
    • 小売薬局
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ地域
    • 南米

第6章 競合情勢

  • 企業プロファイル
    • Pfizer Inc.
    • Baxter International Inc.
    • Myungmoon Pharm Co Ltd
    • Alchem International Pvt. Ltd.
    • Caleb Pharmaceuticals, Inc.
    • GlaxoSmithKline plc.
    • Phytex Australia
    • Fine Chemicals Corporation
    • Perrigo Company plc
    • Novartis International AG

第7章 市場機会および将来動向

目次
Product Code: 67968

The market studied is expected to witness CAGR of 6% over the forecast period. The market growth is attributed to the increasing prevalence of motion sickness and growing awareness among the population. Psychological stress is one of the major contributing factors of motion sickness. These psychological factors affect intestinal sensitivity and alteration in the central nervous system. Also, the introduction of novel drug delivery systems such as transdermal patches and adaptation of these dosage forms are expected to bolster the market growth over the forecast period.

Furthermore, the growing number of travellers across the globe, increasing number of surgeries due to chronic conditions is expected to boost the market growth. However, misuse of scopolamine, side effects and stringent regulatory policies are expected to hamper the market growth over the forecast period.

Key Market Trends

Transdermal Patches Anticipated to Grow at Significant Rate

Transdermal patches are widely used nowadays in the treatment of motion sickness. The transdermal patches are prefered due to ease of use, cost-effectiveness and availability. The patch is applied to the hairless skin behind the ear and is used to treat the motion sickness caused by the anaesthesia during the surgeries. According to the world health organization, about 234.2 million major surgeries are performed around the globe every year. Owing to the growing number of surgical interventions across the globe coupled with the launch of new products, the market for transdermal scopolamine patches are expected to grow at a significant rate.

Also, the growing number of domestic and international travellers around the globe and the usage of scopolamine to treat motion sickness during travelling expected to boost market growth over the forecast period.

North America is Expected to have Significant Market Share

North America region is anticipated to have significant market share owing to well-established healthcare infrastructure and the presence of key market players. Also, a growing number of surgeries in the region, an increasing number of travellers coupled with product launches are anticipated to boost the market growth over the forecast period. According to the U.S. Travel Association, U.S. domestic travel has increased by 1.9% in 2018, a total of 2.3 billion person-trips. The Asia Pacific region is expected to grow at significant rates owing to increased expenditure on healthcare, presence of medium and small-sized market players and growing medical tourism for the surgeries in the region.

Competitive Landscape

Global scopolamine market is moderately fragmented and competitive. Market players are focusing on new product launches, product innovations and geographical expansion. The companies operating in the market include Pfizer Inc., Baxter International Inc., Myungmoon Pharm Co Ltd., and Alchem International Pvt. Ltd. among others.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Number of Surgical Interventions due to Chronic Diseases
    • 4.2.2 Rising Healthcare Expenditure and Adaptation of Scopolamine
  • 4.3 Market Restraints
    • 4.3.1 Side Effects and Misuse of Scopolamine
    • 4.3.2 Stringent Regulatory Policies
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Dosage Form
    • 5.1.1 Injectables
    • 5.1.2 Tablets
    • 5.1.3 Transdermal Patches
    • 5.1.4 Others
  • 5.2 By Distribution Channel
    • 5.2.1 Hospital Pharmacies
    • 5.2.2 Retail Pharmacies
    • 5.2.3 Others
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Pfizer Inc.
    • 6.1.2 Baxter International Inc.
    • 6.1.3 Myungmoon Pharm Co Ltd
    • 6.1.4 Alchem International Pvt. Ltd.
    • 6.1.5 Caleb Pharmaceuticals, Inc.
    • 6.1.6 GlaxoSmithKline plc.
    • 6.1.7 Phytex Australia
    • 6.1.8 Fine Chemicals Corporation
    • 6.1.9 Perrigo Company plc
    • 6.1.10 Novartis International AG

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.